These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25249499)

  • 1. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
    Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
    Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
    Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
    Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
    Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
    Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
    Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
    Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
    Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
    Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
    Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achilles and tail tendons of perlecan exon 3 null heparan sulphate deficient mice display surprising improvement in tendon tensile properties and altered collagen fibril organisation compared to C57BL/6 wild type mice.
    Shu CC; Smith MM; Appleyard RC; Little CB; Melrose J
    PeerJ; 2018; 6():e5120. PubMed ID: 30042881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
    Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
    Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
    Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
    J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoglobin over-expression attenuates angiogenic response in hindlimb ischemia in mice.
    Yang YG; Guan H; Liu CW; Li YJ
    Chin Med J (Engl); 2009 May; 122(9):1056-60. PubMed ID: 19493440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of human adipose-derived stromal cells cluster in rat hind-limb ischemia.
    Park IS; Kang JA; Kang J; Rhie JW; Kim SH
    Anat Rec (Hoboken); 2014 Dec; 297(12):2289-98. PubMed ID: 25066828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice.
    Amano K; Okigaki M; Adachi Y; Fujiyama S; Mori Y; Kosaki A; Iwasaka T; Matsubara H
    J Mol Cell Cardiol; 2004 Apr; 36(4):469-80. PubMed ID: 15081307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vascular endothelial growth factor activating transcription factor increases the endothelial progenitor cells population and induces therapeutic angiogenesis in a type 1 diabetic mouse with hindlimb ischemia.
    Diao Y; Lian L; Guo L; Chen H; Chen Y; Song X; Li Y
    Chin Med J (Engl); 2014; 127(20):3623-9. PubMed ID: 25316240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin.
    Egami K; Murohara T; Aoki M; Matsuishi T
    J Leukoc Biol; 2006 May; 79(5):971-6. PubMed ID: 16641139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
    Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
    J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
    Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
    J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transplantation of cord blood endothelial progenitor cells ameliorates limb ischemia].
    Yang C; Zhang ZH; Lu SH; Yang RC; Qian GQ; Han ZC
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1437-41. PubMed ID: 14521750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.